Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.347NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.195NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.321NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.379NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.231NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.299NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.300NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.179NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.125NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
G.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.120NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.249NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.505NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.406NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.115NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.133NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.466NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.489NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.363NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.95NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used